Jose Roberto Cipres Cruces – Trademark Portfolio

Entity Type: 01

Jose Roberto Cipres Cruces holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. The portfolio also extends into Class 30 (Staple Foods) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MORE AGAVE. The owner is based in ZAPOPAN.

PISO 11

AV. REAL ACUEDUCTO NO. 240

ZAPOPAN 45110 , MX

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Jose Roberto Cipres Cruces's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

30
Staple Foods (1 filing)

Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations

Frequently Asked Questions

How many trademarks does Jose Roberto Cipres Cruces have?

Jose Roberto Cipres Cruces has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Jose Roberto Cipres Cruces file in?

Jose Roberto Cipres Cruces files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Jose Roberto Cipres Cruces's most well-known trademarks?

Jose Roberto Cipres Cruces's registered trademark portfolio includes well-known marks such as MORE AGAVE. These are among 1 currently registered trademark in the portfolio.

What is Jose Roberto Cipres Cruces's trademark registration success rate?

Jose Roberto Cipres Cruces has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.